CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 115 enrolled
Drug / intervention
Minimed paradigm Real Time Sytem +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00441129
NCT00441129N/ACompleted
CompareCT.gov

To Assess Whether Type 1 Diabetic Patients Treated With M D I and in Poor Metabolic Control Can Improve Using the Paradigm® Real Time System Compared to Self-Monitoring Blood Glucose and Continuous Subcutaneous Insulin Infusion

Medtronic MiniMed, Inc.·interventional·Posted Feb 28, 2007·Updated Dec 5, 2018

In Brief

A clinical study evaluating Minimed paradigm Real Time Sytem and Minimed Paradigm 512/712 Insulin pump for Type 1 Diabetes. Completed, enrolled 115 participants across 8 sites.

Detailed Summary

In this study, subjects with insufficient metabolic control despite optimized basal-bolus injection regimens were randomily assigned to either the Mini- Med Paradigm REAL-Time insulin pump (PRT), an insulin pump that can receive and display CGM data from a separate subcutaneous glucose sensor, or conventional CSII, and compared glycemic outcomes after 6 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 28, 2007
Enrollment StartJun 1, 2006
Primary CompletionMay 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 19.3 years ago

Interventions

Minimed paradigm Real Time Sytemdevice

Minimed paradigm Real Time Sytem

Minimed Paradigm 512/712 Insulin pumpdevice

Minimed Paradigm 512/712 Insulin pump